DIP
BMY icon

Davis Investment Partners’s Bristol-Myers Squibb BMY Stock Holding History

Davis Investment Partners’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$886K Buy
15,381
+1,271
+9% +$73K 0.27% 63
2026
Q1 		$856K Buy
14,110
+1,306
+10% +$76.1K 0.3% 59
2025
Q4 		$684K Sell
12,804
-137
-1% -$6.59K 0.24% 72
2025
Q3 		$614K Sell
12,941
-1,261
-9% -$58.9K 0.21% 80
2025
Q2 		$675K Sell
14,202
-3,022
-18% -$148K 0.24% 73
2025
Q1 		$884K Buy
17,224
+9,912
+136% +$578K 0.39% 45
2024
Q4 		$408K Buy
+7,312
New +$409K 0.17% 87

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Davis Investment Partners's BMY Position: Q2 2026 in Review

Davis Investment Partners increased its Bristol-Myers Squibb (BMY) stake by 9% in Q2 2026, buying an estimated $73K and bringing the position to 15,381 shares worth $886K. The position accounts for 0.27% of the portfolio, ranked #63.

Davis Investment Partners first reported a position in BMY in Q4 2024 and has held it in 7 quarters since. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Davis Investment Partners held 15,381 shares of Bristol-Myers Squibb worth $886K as of Q2 2026.
  • Davis Investment Partners bought 1,271 Bristol-Myers Squibb shares in Q2 2026, an estimated $73K.
  • Bristol-Myers Squibb made up 0.27% of Davis Investment Partners's portfolio in Q2 2026, its #63 holding.
  • Davis Investment Partners first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 7 quarters since.
  • 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Davis Investment Partners's 13F filing for Q2 2026, filed 7 Aug 2026.